» Articles » PMID: 12584142

Platelet-endothelial Interaction in Tumor Angiogenesis and Microcirculation

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2003 Feb 14
PMID 12584142
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Activated platelets release angiogenic growth factors and have therefore been proposed to contribute to tumor angiogenesis within a potentially prothrombotic tumor microcirculation. The aim of the study was to investigate interactions of platelets with the angiogenic microvascular endothelium of highly vascularized solid tumors during growth and in response to endothelial stimulation in comparison with normal subcutaneous tissue. Experiments were performed in the dorsal skinfold chamber preparation of C57BL/6J mice bearing the Lewis lung carcinoma (LLC-1) or methylcholanthrene-induced fibrosarcoma (BFS-1). Fluorescently labeled rolling and adherent platelets, red blood cell velocity, and vessel diameters were assessed by intravital fluorescence microscopy on days 1, 3, 8, and 14 after tumor cell implantation. Slightly elevated numbers of rolling platelets were observed in the early stages of tumor angiogenesis at day 1 (control, 1.7 +/- 0.6; LLC-1, 3.4 +/- 1.8; BFS-1, 3.0 +/- 0.7 [1/mm/s], P <.05) and day 3 (control, 1.6 +/- 0.6; LLC-1, 4.1 +/- 1.7, P <.05; BFS-1, 2.3 +/- 0.5 [1/mm/s]) after tumor cell implantation. Endothelial stimulation with calcium ionophore A23187 at day 14 after tumor cell implantation resulted in a minor increase to 2.1 +/- 0.4 (LLC-1) and 1.8 +/- 0.8 (BFS-1) rolling platelets (1/mm/s) in tumor microvessels compared with 4.9 +/- 0.9 in controls (P <.05). Platelet adherence was not observed. We therefore conclude that in the 2 experimental tumors under study, (1) slightly increased platelet rolling is a transient phenomenon after tumor cell implantation, and (2) platelet-endothelial interaction in response to endothelial stimulation is reduced in tumor microvessels.

Citing Articles

Clonorchis sinensis infection contributes to hepatocellular carcinoma progression via enhancing angiogenesis.

Wei C, Chen J, Yu Q, Qin Y, Huang T, Liu F PLoS Negl Trop Dis. 2024; 18(11):e0012638.

PMID: 39527585 PMC: 11554034. DOI: 10.1371/journal.pntd.0012638.


The localization, origin, and impact of platelets in the tumor microenvironment are tumor type-dependent.

Le Chapelain O, Jadoui S, Gros A, Barbaria S, Benmeziane K, Ollivier V J Exp Clin Cancer Res. 2024; 43(1):84.

PMID: 38493157 PMC: 10944607. DOI: 10.1186/s13046-024-03001-2.


The dynamic role of platelets in cancer progression and their therapeutic implications.

Li S, Lu Z, Wu S, Chu T, Li B, Qi F Nat Rev Cancer. 2023; 24(1):72-87.

PMID: 38040850 DOI: 10.1038/s41568-023-00639-6.


C3G promotes a selective release of angiogenic factors from activated mouse platelets to regulate angiogenesis and tumor metastasis.

Martin-Granado V, Ortiz-Rivero S, Carmona R, Gutierrez-Herrero S, Barrera M, San-Segundo L Oncotarget. 2018; 8(67):110994-111011.

PMID: 29340032 PMC: 5762300. DOI: 10.18632/oncotarget.22339.


Microvasculature on a chip: study of the Endothelial Surface Layer and the flow structure of Red Blood Cells.

Tsvirkun D, Grichine A, Duperray A, Misbah C, Bureau L Sci Rep. 2017; 7:45036.

PMID: 28338083 PMC: 5364477. DOI: 10.1038/srep45036.